These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 20031691
1. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691 [Abstract] [Full Text] [Related]
2. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry. Goswami NJ, Gaffigan M, Berrio G, Plessa AL, Pfeiffer AM, Markwell SJ, Mishkel GJ. Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):93-100. PubMed ID: 19787803 [Abstract] [Full Text] [Related]
8. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study). Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D. J Interv Cardiol; 2008 Aug 01; 21(4):315-24. PubMed ID: 18754967 [Abstract] [Full Text] [Related]
9. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents. Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ, Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators. Circulation; 2009 Aug 04; 120(5):400-7. PubMed ID: 19620506 [Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions. Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B. Chin Med J (Engl); 2010 Apr 05; 123(7):789-93. PubMed ID: 20497665 [Abstract] [Full Text] [Related]
18. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS, ARRIVE 1 and ARRIVE 2 Participating Physicians. Circ Cardiovasc Interv; 2009 Aug 05; 2(4):285-93. PubMed ID: 20031730 [Abstract] [Full Text] [Related]
19. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry. Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO. J Am Coll Cardiol; 2007 Nov 20; 50(21):2029-36. PubMed ID: 18021868 [Abstract] [Full Text] [Related]
20. Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation. Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys PW. Circ Cardiovasc Interv; 2008 Oct 20; 1(2):103-10. PubMed ID: 20031664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]